[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:primary-graft-dysfunction":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Primary Graft Dysfunction",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06853223","This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction",[11],"Phase 2","RECRUITING","2026-08-26T02:18:03.638950Z","2026-05-05T02:43:27.845680Z",[],[]]